Challenge assumptions and reset expectations when it comes to pre-launch SG&A investment to increase the odds of commercial success.
Sachin Purwar
Advertisement
Director, Commercial Advisory Group, Syneos Health Consulting
Articles by Sachin Purwar
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Agentic AI Will Transform the Business of Life Sciences
2
How Can Harvard Business School Students and Alumni Prepare for Their Long-Term Career Journeys in an Accelerating AI-Focused Society?
3
Novo Nordisk’s New Board: A Shift Back to Science & Operations But a Step Away From Commercial Priorities?
4
ABL Bio Enters $2.6 Billion Multi-Program Collaboration Agreement with Eli Lilly
5
